Please log in to view this page
Username
Password
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
